It is thought that PLP and DM20 are likely major targets of the autoimmune response in MS [15], since they are highly encephalitogenic in animals [16–20], and autoreactivity directed against PLP is elevated in patients with MS, as discussed further below. This evidence concerns the gene PLP1 and myeloid sarcoma.